Section of Emergency Medicine, Children's Hospital Colorado, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colo.
Child Health Biostatistics Core, Children's Hospital Colorado, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colo.
J Allergy Clin Immunol Pract. 2023 May;11(5):1450-1458.e1. doi: 10.1016/j.jaip.2022.12.033. Epub 2023 Jan 5.
An agreed-upon definition of treatment response for clinical trials of pediatric acute asthma does not exist, limiting meaningful comparisons among therapeutic interventions and advances in asthma management.
To develop a consensus definition of treatment response for clinical trials of pediatric acute asthma.
A multidisciplinary panel of 22 experts participated in a Web-based modified Delphi process to achieve consensus on a definition of treatment response. Round 1 consisted of closed- and open-ended questions in which panelists ranked measures of treatment response developed by literature review, suggested additional measures, and explained their responses. In rounds 2 and 3, panelists reviewed summary statistics of the panel's rating from prior rounds and reconsidered their rankings. In round 3, pairwise ranking was performed to determine the ranked importance of components. Consensus was defined as 70% or greater agreement among panelists choosing Likert-scale values of 1 to 6 (extremely unimportant to extremely important) and an interquartile range less than 2.
Drawing on results from the expert panel, we developed a definition of treatment response that includes Clinical Severity Score, need for additional therapies, and hospitalization. Clinical Severity Score encompassed most ranked criteria (eg, respiratory distress, wheeze) for a treatment response definition. Panelists recommended that a valid and pragmatic severity score be used consistently across institutions. Panelists also achieved consensus on the top 10 criteria that appropriately classify need for hospitalization.
This consensus definition of treatment response can be used in clinical trials of children with acute asthma to standardize outcome measurement and report meaningful outcomes.
目前,儿科急性哮喘临床试验中并没有一个被广泛认可的治疗反应定义,这限制了治疗干预措施之间以及哮喘管理进展方面的有意义比较。
制定儿科急性哮喘临床试验中治疗反应的共识定义。
由 22 名多学科专家组成的小组参与了一项基于网络的改良 Delphi 流程,以就治疗反应的定义达成共识。第一轮包括封闭和开放式问题,小组成员根据文献综述对治疗反应的衡量标准进行排名,提出了其他衡量标准,并解释了他们的回答。在第二轮和第三轮中,小组成员查看了前几轮小组评分的汇总统计数据,并重新考虑了他们的排名。在第三轮中,进行了两两排名,以确定组件的排名重要性。共识定义为 70%或以上的小组成员选择 1 到 6(极不重要到极重要)的李克特量表值,并具有小于 2 的四分位距。
根据专家小组的结果,我们制定了一个治疗反应的定义,其中包括临床严重程度评分、需要额外的治疗和住院治疗。临床严重程度评分涵盖了治疗反应定义中大多数排名靠前的标准(例如呼吸窘迫、喘息)。小组成员建议在各个机构中一致使用有效且实用的严重程度评分。小组成员还就适当分类住院需求的前 10 个标准达成了共识。
这个治疗反应的共识定义可用于儿科急性哮喘的临床试验中,以标准化结果测量并报告有意义的结果。